leave a message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
OPACT® DMCC 30 is a novel co-processed pharmaceutical excipient composed of mannitol, microcrystalline cellulose, crospovidone, and colloidal silicon dioxide. It is specifically engineered for oral fast-disintegrating tablets, ensuring rapid disintegration and a pleasant mouthfeel.
Item No :
OPACT® DMCC 30Product Origin :
CHINAShipping Port :
SHANG HAIPayment :
TT/LCWeight :
20/25KGOrder(MOQ) :
100KG
OPACT® DMCC 30 is a newly developed co-processed excipient by Westpoint Pharma, designed specifically for oral fast-disintegrating tablets (ODT). This innovative formulation synergizes the functional properties of its components to achieve rapid disintegration within the oral cavity. Beyond its primary function of quick dissolution, it delivers a pleasant mouthfeel, making it an ideal choice for patient-centric solid oral dosage forms.
The primary application of OPACT® DMCC 30 lies in the development and production of orally disintegrating tablets (ODT). As a specialized co-processed excipient, it meets the critical demand for rapid disintegration within the mouth, making it an optimal choice for solid oral dosage forms that require quick dissolution without water. Its excellent mouthfeel also makes it highly suitable for formulations where patient compliance and sensory experience are top priorities.
| Loss on Drying (%) | Bulk Density (g/ml) |
Packaging Size (kg) |
|---|---|---|
|
≤ 4.0 |
0.40-0.60 |
20 |
OPACT® SMCC 50 is a silicified microcrystalline cellulose excipient made of 98% MCC and 2% colloidal silicon dioxide by co-processing. It delivers excellent compressibility and good flowability for direct compression and dry granulation in oral solid dosage forms.
Read More
OPACT® SMCC 90 is a silicified microcrystalline cellulose excipient combining 98% MCC with 2% colloidal silicon dioxide. It offers the optimal balance of flowability and compressibility for direct compression and dry granulation in oral solid dosage forms.
Read More
OPACT® DMCC 25 is a co-processed excipient composed of mannitol, microcrystalline cellulose, and silicon dioxide. Designed for pharmaceutical and health food applications, it is specifically engineered to support the formulation and production of orally disintegrating tablets.
Read More
OPACT® MCPP is Westpoint's co-processed direct compression premix composed of D-mannitol, crospovidone, polyvinyl acetate, and povidone. Engineered for orally disintegrating tablets (ODTs), it combines filling, binding, and disintegrating functions in one free-flowing powder — enabling simple blending with APIs and lubricants for direct tableting.
Read More
OPACT® LMCC is a co-processed pharmaceutical excipient composed of 75% alpha-lactose monohydrate and 25% microcrystalline cellulose, specifically designed for direct compression as a high-performance filler and binder in tablets, capsules, and granules.
Read More
OPACT® LPCC is a co-processed pharmaceutical excipient combining lactose and powdered cellulose. It offers excellent compressibility, flowability, and disintegration, serving as a versatile multifunctional filler and binder for solid dosage formulations.
Read More
OPACT® LPC is a co-processed pharmaceutical excipient combining lactose monohydrate, povidone, and crospovidone into a single free-flowing premix. Engineered for direct compression and hard capsule filling, it integrates filler, binder, and disintegrant functions in one standardized system, helping pharmaceutical manufacturers streamline formulation and accelerate tablet production.
Read More
English
français
русский
español
العربية
Indonesia